The cardiovascular diseases which include heart attacks, strokes, and other circulatory diseases have become the leading cause of premature deaths. According to the World Health Organization, 2017, cardiovascular diseases account for nearly 17.9 million deaths per year, and this number is expected to grow to more than 23.6 million by 2030. Hence, the increasing number of cardiovascular diseases is driving the demand for angiography devices, which may ultimately result in the growth of the angiography devices market. Furthermore, other factors, such as rapid technological advances, increasing awareness of the population, and a high preference for minimally invasive procedures, are supplementing the market growth.
Key Market Trends
The Hospital Segment is Expected to Dominate the Market During the Forecast Period
The main factors attributing to the dominance of the hospital segment are the availability of the larger patient pool, high resource availability, high penetration in diverse geographical locations, availability of accompanying healthcare infrastructure and procedures, availability of skilled labor, and affordability via government funding. A large number of complex cardiac disease cases are on the rise, with the growth in the number of deaths due to cardiovascular diseases, across both the developed and emerging markets. The high accessibility and affordability of hospitals, as compared to the specialty clinics, attract a large patient population suffering from cardiovascular diseases. The profitability index of hospitals also increases, as they benefit from the bulk purchase discounts and trade agreements with the manufacturers and suppliers. Furthermore, these trade agreements open new avenues to timely upgradation and early access to technologically advanced products by the manufacturers, enhancing the hospital’s treatment capability.
North America Dominates the Angiography Devices Market
North America dominates the angiography devices market, owing to the high adoption rate of minimally invasive procedures, availability of reimbursements, rising geriatric population, and high replacement rates of medical equipment. Factors, such as a good network of medical device companies and a large number of hospitals across cities and states with good funding opportunities, primarily help the region dominate the market. Furthermore, good support from government facilities helps in the development required for the overall treatment of cardiovascular diseases in the healthcare sector of the region.
Europe is the second-largest market after North America. The significant share of the European countries can be attributed to the high prevalence of cardiovascular diseases, high government investments, faster product approval procedures, and rising adoption of angiography devices due to a large number of angiography screening procedures being performed.
The angiography devices market is consolidated and highly competitive. A few global players dominate the market, primarily due to the stringent product approval process, along with the need for significant technological capabilities. The key market players include AngioDynamics Inc., Boston Scientific Corporation, Canon Medical Systems Corporation, Cardinal Health Inc., GE Healthcare, Medtronic PLC, Koninklijke Philips NV, Shimadzu Corporation, Siemens Healthineers AG, and Terumo Corporation.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support